![Omicron BA.4BA.5](https://www.adcreviews.com/wp-content/uploads/2022/08/Omicron-BA-4BA-5-300x200.jpeg)
Pfizer and BioNTech Submit Emergency Use Authorization Application to FDA for Omicron Bivalent Vaccine
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S.